Best in Biotech 31 Dec 2018
European Biotech’s Biggest News of 2018
…to get FDA approval in 2019. Another diabetes treatment entered the clinic in April, but this time, it was cheesy. The Belgian company ActoBio Therapeutics hopes to treat type 1…
Search Results for: T cells
News and Trends 16 Nov 2017
Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists
…Bergen have been testing hundreds of drugs to see how they affect cancer cells. They have now found a drug taken to treat intestinal parasites, Giardia and tapeworms, which acts…
Interview 23 Jan 2017
“Senior Staff Snobbery separates Academia from the Biotech Industry”
…is that most academics are only interested in treating the patients for publications. Moreover, they try very experimental therapies without reliable animal models: these studies are the worst ‘first-in-man’ trials…
Expert Advice 7 Sep 2019
Why Being in a New Field From the Start Can Pay Off in the Long Run
…say 2006, even 2007 – and talking to them about immunology or immuno-oncology or T-cells. The typical answer was, ‘We don’t believe in that. These are T-cells. We don’t think…
ADVERTISEMENT
News and Trends 14 Dec 2016
Swedish Therapy targeting All Solid Tumors enrolls First Patient
Immunicum just received FDA approval to start clinical trials in the US for a therapy that could overcome the challenges of T-cell therapies and target virtually any injectable solid tumor….
Best in Biotech 16 May 2025
Nine promising small molecule drug discovery companies to look out for in 2025
…to discover small molecule inhibitors 858 Therapeutics is developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology and immunology. The company says that it…
News and Trends 1 Mar 2017
Swedish Oncology Biotech makes a Large IPO for its Peptides
…by peptidase enzymes, which impair transport of its active cancer-fighting agents out of the cell and at the same time drives the transport of more Ygalo molecules into the cell….
News and Trends 24 Aug 2022
Oncolyze seeking investment for AML clinical trials
…also found on the cell surface of many types of cancer cells, but not normal cells. OM-301 has two components. The first, a targeting segment, finds the HDM2 residing on…
News and Trends 14 Nov 2022
New therapy transitions toxic immune cells from harmful to healing to fight effects of hyperinflammation in children
…it has fallen and caused a flood. Cell-directed extracorporeal therapy works at the cellular level to manage the clouds and stop the storm at its source so that it doesn’t…
In Depth 25 May 2020
Could Cell Therapy Target the Symptoms of Severe Covid-19?
…their respective clinical trials fairly quickly. But it is likely that we will have to wait for a few more months at least to find out whether these cell therapies…
News and Trends 26 Jan 2023
Milestone for gene-edited therapy for sickle cell disease
…and transfusion-dependent beta thalassemia (TDT). The submission is supported by two global phase 3 studies investigating exa-cel as a potential one-time therapy for people with SCD or TDT. “Today marks…
